Has the Indonesian Pharma Industry valuation changed over the past few years?
|Fri, 21 Jan 2022||Rp118.8t||Rp63.2t||Rp5.1t||24.7x|
|Sun, 19 Dec 2021||Rp118.0t||Rp63.1t||Rp5.1t||24.7x|
|Tue, 16 Nov 2021||Rp114.7t||Rp60.3t||Rp4.4t||25x|
|Thu, 14 Oct 2021||Rp106.4t||Rp58.5t||Rp4.3t||21.1x|
|Sat, 11 Sep 2021||Rp107.9t||Rp57.5t||Rp4.3t||23.1x|
|Mon, 09 Aug 2021||Rp98.1t||Rp57.5t||Rp4.3t||20.4x|
|Sun, 02 May 2021||Rp108.5t||Rp56.1t||Rp4.1t||24.3x|
|Wed, 03 Feb 2021||Rp113.0t||Rp55.7t||Rp4.0t||22.1x|
|Sat, 07 Nov 2020||Rp118.2t||Rp54.4t||Rp3.9t||19.1x|
|Fri, 31 Jul 2020||Rp105.1t||Rp48.8t||Rp3.7t||15.7x|
|Mon, 04 May 2020||Rp88.2t||Rp49.5t||Rp3.6t||9.9x|
|Thu, 06 Feb 2020||Rp85.5t||Rp48.3t||Rp3.5t||11x|
|Sun, 10 Nov 2019||Rp105.0t||Rp47.7t||Rp3.7t||12.2x|
|Sat, 03 Aug 2019||Rp106.3t||Rp47.1t||Rp3.7t||14x|
|Tue, 07 May 2019||Rp115.2t||Rp45.9t||Rp3.8t||15.3x|
|Fri, 08 Feb 2019||Rp119.9t||Rp44.8t||Rp3.8t||14.6x|
Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 24.7x which is higher than its 3-year average PE of 17.1x. It appears they are confident that earnings will grow faster in the future than they have historically.
Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 10% per year over the last three years, and revenues for these companies have grown 12% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the Indonesian Pharma industry?
Industry PE: Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 17.1x. However analysts are expecting annual earnings growth of 2.7%, which is lower than the prior year's growth of 15% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 2.7% over the next 5 years. However this is lower than its past earnings growth rate of 15% per year.
Soho Global Health
Kimia Farma (Persero)
Tempo Scan Pacific